Sensus Healthcare Q1 revenue falls to $3.4 million from $8.3 million
Sensus Healthcare reported first-quarter 2026 revenue of $3.4 million, down from $8.3 million a year earlier, as it shipped 14 systems versus 30 and had no direct sales to its historically largest customer. Net loss was $2.6 million, or $0.16 per share, matching the prior-year quarter only because of a $1.6 million income tax benefit, while Adjusted EBITDA worsened to negative $4.2 million.
Key points
- Revenue was $3.4 million versus $8.3 million for Q1 2025; the company shipped 14 SRT systems versus 30 in the prior-year period.
- Net loss was $2.6 million, or $0.16 per share, the same per-share loss as Q1 2025, and included a $1.6 million income tax benefit.
- Adjusted EBITDA was negative $4.2 million, compared with negative $2.5 million in Q1 2025.
- Cash and cash equivalents were $18.3 million at March 31, 2026, down from $22.1 million at December 31, 2025, with no debt.
The filing
Written by AI on Nov 9, 2026, 10:08 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 07, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.